New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
15:33 EDTOMEDOncoMed price target raised to $48 from $38 at Piper Jaffray
Piper Jaffray raised its price target on OncoMed to $48 citing pancreatic cancer data presented at the ASCO-GI symposium.
News For OMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
08:40 EDTOMEDOncoMed completes enrollment of tarextumab Phase 2 ALPINE clinical trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use